700 patients110,866 observations180 daysLIVE

Patient P-02565

Synthetic patientMETA-24 · Day 170 · 25–34 · M · baseline S09Open companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S09
  2. Day 113 DT-01 recommendedDosing / Timing Recommendation DT-01
  3. Day 114 Patient acceptedStarted DT-01 in the companion
  4. Day 119 No meaningful changeDosing / Timing Recommendation DT-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+17
  • Nutritional resilience-10
  • Inflammatory activity+7
  • Toxicity-6
  • Treatment adherence+5

What helped?

  • Dosing / Timing Recommendation DT-01Day 113
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 45
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 4.4 · butyrate capacity 76/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
58 ms
Sleep
7.1 h
Steps
8,472
Resting HR
66 bpm
Daily log: GI score 21, nutritional resilience 65, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0255546%S01AD-05no change79
P-0220443%S0170
P-0225743%S0181
P-0213742%S0181
P-0259242%S0174
P-0227541%S0184
P-0228240%S01BR-03no change88
P-0260040%S0187
P-0234238%S0176
P-0262037%S01HY-01improved64
P-0213836%S0179
P-0221733%S0161